These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 6668100

  • 1. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D.
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [Abstract] [Full Text] [Related]

  • 6. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ, Cefali EA, Straughn AB.
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM, Thornley SM, Kramer TH, Armstrong EP.
    Pharmacotherapy; 1990 Mar; 10(5):356-61. PubMed ID: 2122422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S, Raina RK, Samotra K, Gupta KL.
    Indian J Chest Dis Allied Sci; 1991 Mar; 33(1):1-8. PubMed ID: 1791015
    [Abstract] [Full Text] [Related]

  • 18. Absorption of sustained-release theophylline tablets.
    Fagerström PO, Heintz L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.